Pfeffer LM - Search Results

1

Next-generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma.

Yang C, He Y, Wang Y, McKinnon PJ, Shahani V, Miller DD, Pfeffer LM. Yang C, et al. Among authors: pfeffer lm. J Cell Mol Med. 2023 Sep;27(18):2770-2781. doi: 10.1111/jcmm.17907. Epub 2023 Aug 18. J Cell Mol Med. 2023. PMID: 37593885 Free PMC article.

2

Brahma-Related Gene-1 (BRG1) promotes the malignant phenotype of glioblastoma cells.

Wang Y, Yang CH, Schultz AP, Sims MM, Miller DD, Pfeffer LM. Wang Y, et al. Among authors: pfeffer lm. J Cell Mol Med. 2021 Mar;25(6):2956-2966. doi: 10.1111/jcmm.16330. Epub 2021 Feb 2. J Cell Mol Med. 2021. PMID: 33528916 Free PMC article.

3

Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma.

Yang C, Wang Y, Sims MM, He Y, Miller DD, Pfeffer LM. Yang C, et al. Among authors: pfeffer lm. Pharmaceuticals (Basel). 2021 Sep 6;14(9):904. doi: 10.3390/ph14090904. Pharmaceuticals (Basel). 2021. PMID: 34577604 Free PMC article.

4

Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.

He Y, Yang C, Wang Y, Sacher JR, Sims MM, Pfeffer LM, Miller DD. He Y, et al. Among authors: pfeffer lm. Bioorg Med Chem. 2022 Jan 1;53:116533. doi: 10.1016/j.bmc.2021.116533. Epub 2021 Nov 27. Bioorg Med Chem. 2022. PMID: 34863065

5

STAT3 suppresses the AMPKα/ULK1-dependent induction of autophagy in glioblastoma cells.

Bhattacharya S, Yin J, Yang C, Wang Y, Sims M, Pfeffer LM, Chaum E. Bhattacharya S, et al. Among authors: pfeffer lm. J Cell Mol Med. 2022 Jul;26(14):3873-3890. doi: 10.1111/jcmm.17421. Epub 2022 Jun 6. J Cell Mol Med. 2022. PMID: 35670018 Free PMC article.

6

Chromenes: potential new chemotherapeutic agents for cancer.

Patil SA, Patil R, Pfeffer LM, Miller DD. Patil SA, et al. Among authors: pfeffer lm. Future Med Chem. 2013 Sep;5(14):1647-60. doi: 10.4155/fmc.13.126. Future Med Chem. 2013. PMID: 24047270 Review.

7

SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo.

Wang Y, Yang C, Sims MM, Sacher JR, Raje M, Deokar H, Yue P, Turkson J, Buolamwini JK, Pfeffer LM. Wang Y, et al. Among authors: pfeffer lm. Cancer Lett. 2022 May 1;533:215614. doi: 10.1016/j.canlet.2022.215614. Epub 2022 Mar 1. Cancer Lett. 2022. PMID: 35245627

8

Novel approaches to glioma drug design and drug screening.

Patil SA, Hosni-Ahmed A, Jones TS, Patil R, Pfeffer LM, Miller DD. Patil SA, et al. Among authors: pfeffer lm. Expert Opin Drug Discov. 2013 Sep;8(9):1135-51. doi: 10.1517/17460441.2013.807248. Epub 2013 Jun 6. Expert Opin Drug Discov. 2013. PMID: 23738794 Review.

9

Identification of imidazoquinoline derivatives as potent antiglioma agents.

Patil SA, Pfeffer SR, Seibel WL, Pfeffer LM, Miller DD. Patil SA, et al. Among authors: pfeffer sr, pfeffer lm. Med Chem. 2015;11(4):400-6. doi: 10.2174/1573406410666140914162701. Med Chem. 2015. PMID: 25219925

10

EDL-360: A Potential Novel Antiglioma Agent.

Hosni-Ahmed A, Sims M, Jones TS, Patil R, Patil S, Abdelsamed H, Yates CR, Miller DD, Pfeffer LM. Hosni-Ahmed A, et al. Among authors: pfeffer lm. J Cancer Sci Ther. 2014 Sep 25;6(9):370-377. doi: 10.4172/1948-5956.1000295. J Cancer Sci Ther. 2014. PMID: 25574358 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page